STAT3 and breast carcinoma: This approach is clinically relevant, as a similar CAF-STAT3 signature is highly expressed in stromal cells of breast cancer patients, particularly those with basal-like disease, and is linked to shorter disease-specific survival (Chen et al., 2024).